Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Mullard

Showing results (131-140 of 684) with videos related to

Pageof 69
Sort By:
Nature Reviews. Drug Discovery|April 14, 2021
Blood-brain barrier-traversing biologic secures regulatory approval, in JapanAsher Mullard
Nature Reviews. Drug Discovery|April 16, 2025
Back to the drawing board for anhedonia drugsAsher Mullard
Nature Reviews. Drug Discovery|July 31, 2025
Oncolytic virus drought continues, as Replimune fails to secure FDA cancer approvalAsher Mullard
Nature Reviews. Drug Discovery|August 8, 2020
RSV antibody showcases passive immunotherapy progressAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2024
Bispecific antibody takes a BiTE out of B cells in rheumatoid arthritisAsher Mullard
Nature Reviews. Drug Discovery|April 2, 2015
The Roadmap Epigenomics Project opens new drug development avenuesAsher Mullard
Nature Reviews. Drug Discovery|January 31, 2015
2014 FDA drug approvalsAsher Mullard
Nature Reviews. Drug Discovery|September 9, 2024
PPAR agonists provide new treatment options for inflammatory liver diseaseAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves IDH1 and IDH2 inhibitor for brain cancerAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2021
Entasis antibiotic shows phase III promiseAsher Mullard
Pageof 69

Showing results (131-140 of 684) with videos related to

Sort By:
Pageof 69
Nature Reviews. Drug Discovery|April 14, 2021
Blood-brain barrier-traversing biologic secures regulatory approval, in JapanAsher Mullard
Nature Reviews. Drug Discovery|April 16, 2025
Back to the drawing board for anhedonia drugsAsher Mullard
Nature Reviews. Drug Discovery|July 31, 2025
Oncolytic virus drought continues, as Replimune fails to secure FDA cancer approvalAsher Mullard
Nature Reviews. Drug Discovery|August 8, 2020
RSV antibody showcases passive immunotherapy progressAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2024
Bispecific antibody takes a BiTE out of B cells in rheumatoid arthritisAsher Mullard
Nature Reviews. Drug Discovery|April 2, 2015
The Roadmap Epigenomics Project opens new drug development avenuesAsher Mullard
Nature Reviews. Drug Discovery|January 31, 2015
2014 FDA drug approvalsAsher Mullard
Nature Reviews. Drug Discovery|September 9, 2024
PPAR agonists provide new treatment options for inflammatory liver diseaseAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves IDH1 and IDH2 inhibitor for brain cancerAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2021
Entasis antibiotic shows phase III promiseAsher Mullard
Pageof 69